Results
30
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
30 companies
Zhejiang Leapmotor Technology
Market Cap: HK$71.6b
Engages in the research and development, production, and sale of new energy vehicles in Mainland China and internationally.
9863
HK$53.55
7D
-0.8%
1Y
100.9%
Jiangxi Rimag Group
Market Cap: HK$4.6b
Invests and operates medical imaging centers in China.
2522
HK$12.58
7D
-7.9%
1Y
-30.1%
ASMPT
Market Cap: HK$22.1b
An investment holding company, engages in the design, manufacture, and marketing of machines, tools, and materials used in the semiconductor and electronics assembly industries worldwide.
522
HK$53.05
7D
-2.4%
1Y
-45.2%
Intron Technology Holdings
Market Cap: HK$1.5b
An investment holding company, operates as an automotive electronics solutions provider in Hong Kong, the Mainland China, and internationally.
1760
HK$1.40
7D
-5.4%
1Y
-9.7%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$6.1b
Beijing Chunlizhengda Medical Instruments Co., Ltd.
1858
HK$10.80
7D
-6.9%
1Y
15.8%
Acotec Scientific Holdings
Market Cap: HK$2.3b
Operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally.
6669
HK$7.21
7D
-5.3%
1Y
6.7%
WEILONG Delicious Global Holdings
Market Cap: HK$32.1b
Produces and sells spicy snack food in the People’s Republic of China and internationally.
9985
HK$13.20
7D
-11.3%
1Y
110.9%
Beijing Fourth Paradigm Technology
Market Cap: HK$23.9b
An investment holding company, provides platform-centric artificial intelligence (AI) solutions in the People's Republic of China.
6682
HK$48.45
7D
3.0%
1Y
-3.4%
RemeGen
Market Cap: HK$34.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$52.00
7D
-2.9%
1Y
98.5%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$73.6b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$322.20
7D
-7.1%
1Y
86.5%
Akeso
Market Cap: HK$81.9b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$91.30
7D
-4.7%
1Y
156.1%
Lingbao Gold Group
Market Cap: HK$13.0b
Primarily engages in mining, processing, smelting, refining, and sale of gold products in the People’s Republic of China.
3330
HK$10.08
7D
-20.0%
1Y
230.5%
BYD
Market Cap: HK$1.1t
Engages in automobiles and batteries business in the People’s Republic of China, Hong Kong, Macau, Taiwan, and internationally.
1211
HK$125.80
7D
-4.0%
1Y
59.8%
Bairong
Market Cap: HK$3.6b
Operates as a cloud-based AI turnkey services provider in China.
6608
HK$8.20
7D
0%
1Y
-8.8%
Innovent Biologics
Market Cap: HK$128.3b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$77.70
7D
-3.7%
1Y
111.1%
Genscript Biotech
Market Cap: HK$31.6b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$14.50
7D
-10.7%
1Y
70.8%
Plover Bay Technologies
Market Cap: HK$6.3b
An investment holding company, designs, develops, and markets software defined wide area network routers.
1523
HK$5.67
7D
-4.1%
1Y
75.0%
CSC Financial
Market Cap: HK$175.4b
Provides investment banking services in Mainland China and internationally.
6066
HK$9.34
7D
-4.7%
1Y
52.6%
Chinasoft International
Market Cap: HK$11.5b
Engages in development and provision of information technology (IT) solutions, IT outsourcing, and training services in the People’s Republic of China, the United States, Malaysia, Japan, Singapore, India, and Saudi Arabia.
354
HK$4.62
7D
-7.8%
1Y
13.8%
Nongfu Spring
Market Cap: HK$431.3b
Researches, develops, produces, and markets packaged drinking water and beverage products primarily in Mainland China.
9633
HK$38.35
7D
-2.0%
1Y
-4.5%
Bosideng International Holdings
Market Cap: HK$53.6b
Engages in the apparel business in the People’s Republic of China.
3998
HK$4.68
7D
1.5%
1Y
4.7%
DPC Dash
Market Cap: HK$12.4b
Operates a chain of fast-food restaurants in the People’s Republic of China.
1405
HK$94.40
7D
0.5%
1Y
50.6%
Hua Hong Semiconductor
Market Cap: HK$65.9b
An investment holding company, engages in the manufacture and sale of semiconductor products in China, North America, Asia, Europe, and Japan.
1347
HK$32.75
7D
10.3%
1Y
33.4%
Essex Bio-Technology
Market Cap: HK$2.6b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.55
7D
-10.6%
1Y
83.5%
MicroPort NeuroScientific
Market Cap: HK$7.5b
Engages in the research and development, production, and sale of neuro-interventional medical devices in the People’s Republic of China and internationally.
2172
HK$13.08
7D
6.7%
1Y
85.5%
Viva Biotech Holdings
Market Cap: HK$3.3b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.55
7D
-13.4%
1Y
192.5%
Super Hi International Holding
Market Cap: HK$9.6b
An investment holding company, engages in the restaurant operation, delivery business, and others in Asia, North America, Europe, Oceania, and internationally.
9658
HK$14.74
7D
-5.9%
1Y
22.8%
Hangzhou SF Intra-city Industrial
Market Cap: HK$16.3b
An investment holding company, provides intra-city on-demand delivery services in the People’s Republic of China.
9699
HK$17.86
7D
12.3%
1Y
51.4%
Zhaojin Mining Industry
Market Cap: HK$71.7b
An investment holding company, engages in exploration, mining, processing, smelting, and sale of gold and other metallic products in the People’s Republic of China and internationally.
1818
HK$20.25
7D
-6.7%
1Y
46.1%
Shanghai MicroPort MedBot (Group)
Market Cap: HK$15.7b
Shanghai MicroPort MedBot (Group) Co., Ltd.
2252
HK$15.28
7D
-8.8%
1Y
43.3%